REPORT ID 20445

United States Artificial Tears Market Report 2016

Publish Date
14-Oct
Pages
124
Format
Electronic (PDF)

Notes:
Sales, means the sales volume of Artificial Tears
Revenue, means the sales value of Artificial Tears

This report studies sales (consumption) of Artificial Tears in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
    Bausch and Lomb
    Abott Medical Optics, Inc.
    Johnson and Johnson
    Novartis International AG
    Allergan, Inc.
    Akorn, Inc.
    Santen Pharmaceuticals
    Novagali Pharma S.A.
    NovaMedica
    Alcon, Inc.

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
    Cellulose-derived tears
    Glycerin-derived tears
    Polyethylene glycol and propylene glycol based tears
    Oil-based emulsion tears
    Others
Split by applications, this report focuses on sales, market share and growth rate of  Artificial Tears in each application, can be divided into
    Application 1
    Application 2
    Application 3

 
			   
Table of Contents

United States Artificial Tears Market Report 2016
1 Artificial Tears Overview
    1.1 Product Overview and Scope of Artificial Tears
    1.2 Classification of Artificial Tears
        1.2.1 Cellulose-derived tears
        1.2.2 Glycerin-derived tears
        1.2.3 Polyethylene glycol and propylene glycol based tears
        1.2.4 Oil-based emulsion tears
        1.2.5 Others
    1.3 Application of Artificial Tears
        1.3.1 Application 1
        1.3.2 Application 2
        1.3.3 Application 3
    1.4 United States Market Size Sales (Value) and Revenue (Volume) of Artificial Tears (2011-2021)
        1.4.1 United States Artificial Tears Sales and Growth Rate (2011-2021)
        1.4.2 United States Artificial Tears Revenue and Growth Rate (2011-2021)

2 United States Artificial Tears Competition by Manufacturers
    2.1 United States Artificial Tears Sales and Market Share of Key Manufacturers (2015 and 2016)
    2.2 United States Artificial Tears Revenue and Share by Manufactures (2015 and 2016)
    2.3 United States Artificial Tears Average Price by Manufactures (2015 and 2016)
    2.4 Artificial Tears Market Competitive Situation and Trends
        2.4.1 Artificial Tears Market Concentration Rate
        2.4.2 Artificial Tears Market Share of Top 3 and Top 5 Manufacturers
        2.4.3 Mergers & Acquisitions, Expansion

3 United States Artificial Tears Sales (Volume) and Revenue (Value) by Type (2011-2016)
    3.1 United States Artificial Tears Sales and Market Share by Type (2011-2016)
    3.2 United States Artificial Tears Revenue and Market Share by Type (2011-2016)
    3.3 United States Artificial Tears Price by Type (2011-2016)
    3.4 United States Artificial Tears Sales Growth Rate by Type (2011-2016)

4 United States Artificial Tears Sales (Volume) by Application (2011-2016)
    4.1 United States Artificial Tears Sales and Market Share by Application (2011-2016)
    4.2 United States Artificial Tears Sales Growth Rate by Application (2011-2016)
    4.3 Market Drivers and Opportunities

5 United States Artificial Tears Manufacturers Profiles/Analysis
    5.1 Bausch and Lomb
        5.1.1 Company Basic Information, Manufacturing Base and Competitors
        5.1.2 Artificial Tears Product Type, Application and Specification
            5.1.2.1 Type I
            5.1.2.2 Type II
        5.1.3 Bausch and Lomb Artificial Tears Sales, Revenue, Price and Gross Margin (2011-2016)
        5.1.4 Main Business/Business Overview
    5.2 Abott Medical Optics, Inc.
        5.2.2 Artificial Tears Product Type, Application and Specification
            5.2.2.1 Type I
            5.2.2.2 Type II
        5.2.3 Abott Medical Optics, Inc. Artificial Tears Sales, Revenue, Price and Gross Margin (2011-2016)
        5.2.4 Main Business/Business Overview
    5.3 Johnson and Johnson
        5.3.2 Artificial Tears Product Type, Application and Specification
            5.3.2.1 Type I
            5.3.2.2 Type II
        5.3.3 Johnson and Johnson Artificial Tears Sales, Revenue, Price and Gross Margin (2011-2016)
        5.3.4 Main Business/Business Overview
    5.4 Novartis International AG
        5.4.2 Artificial Tears Product Type, Application and Specification
            5.4.2.1 Type I
            5.4.2.2 Type II
        5.4.3 Novartis International AG Artificial Tears Sales, Revenue, Price and Gross Margin (2011-2016)
        5.4.4 Main Business/Business Overview
    5.5 Allergan, Inc.
        5.5.2 Artificial Tears Product Type, Application and Specification
            5.5.2.1 Type I
            5.5.2.2 Type II
        5.5.3 Allergan, Inc. Artificial Tears Sales, Revenue, Price and Gross Margin (2011-2016)
        5.5.4 Main Business/Business Overview
    5.6 Akorn, Inc.
        5.6.2 Artificial Tears Product Type, Application and Specification
            5.6.2.1 Type I
            5.6.2.2 Type II
        5.6.3 Akorn, Inc. Artificial Tears Sales, Revenue, Price and Gross Margin (2011-2016)
        5.6.4 Main Business/Business Overview
    5.7 Santen Pharmaceuticals
        5.7.2 Artificial Tears Product Type, Application and Specification
            5.7.2.1 Type I
            5.7.2.2 Type II
        5.7.3 Santen Pharmaceuticals Artificial Tears Sales, Revenue, Price and Gross Margin (2011-2016)
        5.7.4 Main Business/Business Overview
    5.8 Novagali Pharma S.A.
        5.8.2 Artificial Tears Product Type, Application and Specification
            5.8.2.1 Type I
            5.8.2.2 Type II
        5.8.3 Novagali Pharma S.A. Artificial Tears Sales, Revenue, Price and Gross Margin (2011-2016)
        5.8.4 Main Business/Business Overview
    5.9 NovaMedica
        5.9.2 Artificial Tears Product Type, Application and Specification
            5.9.2.1 Type I
            5.9.2.2 Type II
        5.9.3 NovaMedica Artificial Tears Sales, Revenue, Price and Gross Margin (2011-2016)
        5.9.4 Main Business/Business Overview
    5.10 Alcon, Inc.
        5.10.2 Artificial Tears Product Type, Application and Specification
            5.10.2.1 Type I
            5.10.2.2 Type II
        5.10.3 Alcon, Inc. Artificial Tears Sales, Revenue, Price and Gross Margin (2011-2016)
        5.10.4 Main Business/Business Overview

6 Artificial Tears Manufacturing Cost Analysis
    6.1 Artificial Tears Key Raw Materials Analysis
        6.1.1 Key Raw Materials
        6.1.2 Price Trend of Key Raw Materials
        6.1.3 Key Suppliers of Raw Materials
        6.1.4 Market Concentration Rate of Raw Materials
    6.2 Proportion of Manufacturing Cost Structure
        6.2.1 Raw Materials
        6.2.2 Labor Cost
        6.2.3 Manufacturing Expenses
    6.3 Manufacturing Process Analysis of Artificial Tears

7 Industrial Chain, Sourcing Strategy and Downstream Buyers
    7.1 Artificial Tears Industrial Chain Analysis
    7.2 Upstream Raw Materials Sourcing
    7.3 Raw Materials Sources of Artificial Tears Major Manufacturers in 2015
    7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders
    8.1 Marketing Channel
        8.1.1 Direct Marketing
        8.1.2 Indirect Marketing
        8.1.3 Marketing Channel Development Trend
    8.2 Market Positioning
        8.2.1 Pricing Strategy
        8.2.2 Brand Strategy
        8.2.3 Target Client
    8.3 Distributors/Traders List

9 Market Effect Factors Analysis
    9.1 Technology Progress/Risk
        9.1.1 Substitutes Threat
        9.1.2 Technology Progress in Related Industry
    9.2 Consumer Needs/Customer Preference Change
    9.3 Economic/Political Environmental Change

10 United States Artificial Tears Market Forecast (2016-2021)
    10.1 United States Artificial Tears Sales, Revenue Forecast (2016-2021)
    10.2 United States Artificial Tears Sales Forecast by Type (2016-2021)
    10.3 United States Artificial Tears Sales Forecast by Application (2016-2021)
    10.4 Artificial Tears Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix
    Author List
    Disclosure Section
    Research Methodology
    Data Source
    Disclaimer